[
    [
        {
            "time": "2023-10-10",
            "original_text": "Why This High-Ranking Medical Stock Can't Seem To Get Traction",
            "features": {
                "keywords": [
                    "High-Ranking",
                    "Medical",
                    "Stock",
                    "Traction"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Why This High-Ranking Medical Stock Can't Seem To Get Traction",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "Is It Worth Considering Abbott Laboratories (NYSE:ABT) For Its Upcoming Dividend?",
            "features": {
                "keywords": [
                    "Abbott",
                    "Laboratories",
                    "Dividend"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Is It Worth Considering Abbott Laboratories (NYSE:ABT) For Its Upcoming Dividend?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]